Handbook Changes at D122 Include Swapping PSAT for PreACT
Students in New Lenox School District 122 will see several changes in the upcoming school year, as the Board of Education approved updates to the 2025-2026 Parent/Student Handbook that affect standardized testing, grading, and health education.
One of the most notable changes is the replacement of the PSAT with the PreACT for eighth-grade testing. This aligns the district’s assessment with the testing used at the high school level.
The board also approved removing standards-based report cards for fourth and fifth-grade math and making a change to the fourth-grade health and sexual education curriculum. Language for the Gifted and Academically Talented Education (GATE) program was also updated to incorporate new classes.
The handbook updates were presented by Associate Superintendent Dr. Liza Bruni and were approved by the board, though not unanimously. Board member Al Haring cast a “nay” vote on the motion, which was part of the consent agenda.
The updated handbook will be made available to parents and students before the start of the 2025-2026 school year.
Latest News Stories
WATCH: Debate around which tax to increase; pension enhancements, energy bills advance
Trump: China to buy U.S. ag products, oil and gas, export rare earth minerals
Illinois quick hits: Energy omnibus bill advancing; ICE protesters indicted
Exclusive: America’s HealthShare launches as alternative to ‘broken’ healthcare system
Senators, pro-life group seek answers on FDA approval of abortion pill
Cartel bounties on ICE agents similar to bounties placed in Texas communities for years
Trump slices China fentanyl tariff in half following meeting with Xi
Trump orders Department of War to begin testing nuclear weapons
WATCH: Tax proposals draw questions from Pritzker and GOP state rep
Illinois quick hits: Former sheriff’s deputy guilty in Massey murder; appeals court intervenes in Bavino case
WATCH: Warnings of higher IL property taxes heard as pension bill advances
Top-selling automaker confirms U.S. investment, but no details yet
Fentanyl poised to take center stage during Trump, Xi meeting